Price target
41.299RCHF+9.573+30.17%
The 6 analysts offering 1 year price forecasts for DERMAPHARM HLDG SE have a max estimate of 46.167 and a min estimate of 33.918.
Analyst rating
Based on 6 analysts giving stock ratings to DERMAPHARM HLDG SE in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
5
Buy
0
Hold
1
Sell
0
Strong sell
0
EPS
Forecast
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−0.30
0.00
0.30
0.60
0.90
Reported
Estimate
Currency: CHF
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
0.45
−0.05
0.79
0.31
0.57
0.36
0.59
—
—
—
Estimate
—
—
—
—
—
—
—
—
—
—
Surprise
—
—
—
—
—
—
—
—
—
—
Revenue
Forecast
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
80.00 M
160.00 M
240.00 M
320.00 M
Reported
Estimate
Currency: CHF
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
275.33 M
249.79 M
290.75 M
269.44 M
294.01 M
273.45 M
289.61 M
—
—
—
Estimate
—
—
—
269.44 M
279.57 M
277.54 M
—
253.56 M
281.13 M
277.40 M
Surprise
—
—
—
0.00%
+5.16%
−1.47%
—
—
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
In the next quarter DERMAPHARM HLDG SE revenue is expected to reach 253.56 M CHF. Check out DERMAPHARM HLDG SE revenue and earnings and make informed decisions.
According to analysts, DMP price target is 41.30 CHF with a max estimate of 46.17 CHF and a min estimate of 33.92 CHF. Check if this forecast comes true in a year, meanwhile watch DERMAPHARM HLDG SE stock price chart and keep track of the current situation with DMP news and stock market news.
We've gathered opinions of 6 analysts rating DMP stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.